Together we will beat cancer

Donate

Kinder and more effective – why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

Read More

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

Read More

New drug combo for advanced breast cancer approved for NHS in England

People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England.

Read More

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

Read More

Scientists developing urine and blood tests to detect brain tumours

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

Read More

A vision for the next decade of UK life sciences

What could the government’s Life Sciences Vision mean for cancer research?

Read More

One in 5 less likely to take part in cancer screening

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

Read More

Blood test could tailor treatment after surgery

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

Read More

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

Read More

Urine test for bladder cancer being developed

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

Read More